FDA Inspection 957571 — Novo Nordisk A/S - 25A-B

Novo Nordisk A/S - 25A-B — FEI 3003131673

The FDA completed an inspection of Novo Nordisk A/S - 25A-B on Jan 22, 2016 in Hillerod. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 22, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Hillerod (Denmark)